• Home
  • Stock
  • Akums Drugs & Pharmaceuticals Fundamental Analysis
  • Akums Drugs & Pharmaceuticals Fundamental Analysis

Akums Drugs & Pharmaceuticals fundamental analysis

AKUMS

HealthcareMid

425.95

6.45 (1.54%)
Last updated on 28 Nov, 2025 | 15:52 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Akums Drugs & Pharmaceuticals Fundamentals

P/E Ratio

21.11

P/B Ratio

2.12

Div. Yield

0

Sector P/E

37.14

Sector P/B

0.85

Sec. Div. Yield

0.56

  • Akums Drugs & Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 21.11, compared to the sector average of 37.14. Its P/B Ratio stands at 2.12, while the sector’s is 0.85. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.56%.

Akums Drugs & Pharmaceuticals Score Card

  • Price

    Attractive

  • Growth

    Average

  • Quality

    Poor

  • Management

    Poor

  • On its scorecard, Akums Drugs & Pharmaceuticals reflects: Price – Attractive, Growth – Average, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.